Oramed: Filed an IND to begin a Phase I/II trial for the topical treatment for oral candidiasis

Biosyn Inc., Philadelphia, Penn. Product: Oramed, synthetic organic molecule Indication: Oral candidiasis in HIV-positive patients Status: Filed an IND to begin a Phase I/II trial for the topical trea...